Biden admin freezes Trump HHS rule meant to lower insulin prices

Desperado

Diamond Member
Mar 13, 2012
40,953
15,884
2,260
Chairman Joe helping his friends in big pharmacy but hurting the people he is supposed to help.....
Biden admin freezes Trump HHS rule meant to lower insulin prices
President Biden has been reversing or pausing some rules put in place under former President Donald Trump this week, including one designed to bring down the price of insulin.
The Department of Health and Human Services on Thursday announced that the directive would be put on hold among a number of other measures that were passed under Trump, but are not yet in effect.


 
For just fucking once I wish OP and Fox would get a story straight. Insurance companies who participated in the lower costs have not stopped a goddamn thing.



The Biden administration on Thursday delayed a rule that would block community health centers from receiving future grant funds unless they charge low-income patients the acquisition price for insulin and Epi-Pens, plus an administration fee.
HHS signed off on the rule in December, shortly before former President Donald Trump left office. It aims to lower patients' out-of-pocket costs by forcing community clinics to pass on their 340B drug discounts. The rule requires federally qualified health centers to give their discounts to the uninsured, patients with high cost-sharing for insulin or Epi-Pens or a high unmet deductible.
It was originally slated to take effect Jan. 22, but HHS delayed it until Mar. 22. The Biden team could eventually withdraw the rule to prevent it from taking effect at all.

Community health centers, patient advocates and other groups pushed back on the rule when HHS proposed it last year, saying the changes were unnecessary and could do more harm than good. The National Association of Community Health Centers has said the rule reflects "a fundamental misunderstanding" of federally qualified health centers and the 340B program. And providers worried the regulation could reduce patients' access to care by cutting deeper into community health centers' thin operating margins.

The rule's pause follows a Wednesday memo from White House Chief of Staff Ron Klain directing agencies to freeze any new regulations ushered in during the end of Trump's term.
The pause will allow the incoming administration "to review any regulations that the Trump administration tried to finalize in its last days," according to a statement. "This action will allow the Biden administration to prevent any detrimental so-called 'midnight regulations' from taking effect while ensuring that urgent measures in the public's interest can proceed."
Republican lawmakers have expressed concern about expanding the 340B drug discount program. But their complaints have generally centered around hospitals, not community health clinics. Federally qualified health centers are legally required to reinvest any savings from 340B in community services, a standard that does not apply to hospitals.
Experts say the rule probably wouldn't make much of a dent in drug prices because it wouldn't affect most providers or patients. HHS admitted as much in its final rule, saying it would have "minimal economic impact."
Letter
 
For just fucking once I wish OP and Fox would get a story straight. Insurance companies who participated in the lower costs have not stopped a goddamn thing.



The Biden administration on Thursday delayed a rule that would block community health centers from receiving future grant funds unless they charge low-income patients the acquisition price for insulin and Epi-Pens, plus an administration fee.
HHS signed off on the rule in December, shortly before former President Donald Trump left office. It aims to lower patients' out-of-pocket costs by forcing community clinics to pass on their 340B drug discounts. The rule requires federally qualified health centers to give their discounts to the uninsured, patients with high cost-sharing for insulin or Epi-Pens or a high unmet deductible.
It was originally slated to take effect Jan. 22, but HHS delayed it until Mar. 22. The Biden team could eventually withdraw the rule to prevent it from taking effect at all.

Community health centers, patient advocates and other groups pushed back on the rule when HHS proposed it last year, saying the changes were unnecessary and could do more harm than good. The National Association of Community Health Centers has said the rule reflects "a fundamental misunderstanding" of federally qualified health centers and the 340B program. And providers worried the regulation could reduce patients' access to care by cutting deeper into community health centers' thin operating margins.

The rule's pause follows a Wednesday memo from White House Chief of Staff Ron Klain directing agencies to freeze any new regulations ushered in during the end of Trump's term.
The pause will allow the incoming administration "to review any regulations that the Trump administration tried to finalize in its last days," according to a statement. "This action will allow the Biden administration to prevent any detrimental so-called 'midnight regulations' from taking effect while ensuring that urgent measures in the public's interest can proceed."
Republican lawmakers have expressed concern about expanding the 340B drug discount program. But their complaints have generally centered around hospitals, not community health clinics. Federally qualified health centers are legally required to reinvest any savings from 340B in community services, a standard that does not apply to hospitals.
Experts say the rule probably wouldn't make much of a dent in drug prices because it wouldn't affect most providers or patients. HHS admitted as much in its final rule, saying it would have "minimal economic impact."
Letter

It would have made a difference to those it helped.
 
For just fucking once I wish OP and Fox would get a story straight. Insurance companies who participated in the lower costs have not stopped a goddamn thing.



The Biden administration on Thursday delayed a rule that would block community health centers from receiving future grant funds unless they charge low-income patients the acquisition price for insulin and Epi-Pens, plus an administration fee.
HHS signed off on the rule in December, shortly before former President Donald Trump left office. It aims to lower patients' out-of-pocket costs by forcing community clinics to pass on their 340B drug discounts. The rule requires federally qualified health centers to give their discounts to the uninsured, patients with high cost-sharing for insulin or Epi-Pens or a high unmet deductible.
It was originally slated to take effect Jan. 22, but HHS delayed it until Mar. 22. The Biden team could eventually withdraw the rule to prevent it from taking effect at all.

Community health centers, patient advocates and other groups pushed back on the rule when HHS proposed it last year, saying the changes were unnecessary and could do more harm than good. The National Association of Community Health Centers has said the rule reflects "a fundamental misunderstanding" of federally qualified health centers and the 340B program. And providers worried the regulation could reduce patients' access to care by cutting deeper into community health centers' thin operating margins.

The rule's pause follows a Wednesday memo from White House Chief of Staff Ron Klain directing agencies to freeze any new regulations ushered in during the end of Trump's term.
The pause will allow the incoming administration "to review any regulations that the Trump administration tried to finalize in its last days," according to a statement. "This action will allow the Biden administration to prevent any detrimental so-called 'midnight regulations' from taking effect while ensuring that urgent measures in the public's interest can proceed."
Republican lawmakers have expressed concern about expanding the 340B drug discount program. But their complaints have generally centered around hospitals, not community health clinics. Federally qualified health centers are legally required to reinvest any savings from 340B in community services, a standard that does not apply to hospitals.
Experts say the rule probably wouldn't make much of a dent in drug prices because it wouldn't affect most providers or patients. HHS admitted as much in its final rule, saying it would have "minimal economic impact."
Letter

It would have made a difference to those it helped.

It has not been stopped at community health clinics, just paused for 60 days.

I'll let you know if insurance companies stop it.
 
Chairman Joe helping his friends in big pharmacy but hurting the people he is supposed to help.....
Biden admin freezes Trump HHS rule meant to lower insulin prices
President Biden has been reversing or pausing some rules put in place under former President Donald Trump this week, including one designed to bring down the price of insulin.
The Department of Health and Human Services on Thursday announced that the directive would be put on hold among a number of other measures that were passed under Trump, but are not yet in effect.




LOL....LOL

Job Killer joe and his first few days are even better than I expected...killing jobs, pissing off our allies, helping Russia and China, and now making drugs more expensive after Trump worked to get those prices lower......

I hope you biden voters are happy with yourselves..


But.....but....duhhhh.....Trump tweeted mean tweets....duhhh.........
 
Chairman Joe helping his friends in big pharmacy but hurting the people he is supposed to help.....
Biden admin freezes Trump HHS rule meant to lower insulin prices
President Biden has been reversing or pausing some rules put in place under former President Donald Trump this week, including one designed to bring down the price of insulin.
The Department of Health and Human Services on Thursday announced that the directive would be put on hold among a number of other measures that were passed under Trump, but are not yet in effect.


It's part of a group is crap that's all being halted until it can be sorted through.
 
For just fucking once I wish OP and Fox would get a story straight. Insurance companies who participated in the lower costs have not stopped a goddamn thing.



The Biden administration on Thursday delayed a rule that would block community health centers from receiving future grant funds unless they charge low-income patients the acquisition price for insulin and Epi-Pens, plus an administration fee.
HHS signed off on the rule in December, shortly before former President Donald Trump left office. It aims to lower patients' out-of-pocket costs by forcing community clinics to pass on their 340B drug discounts. The rule requires federally qualified health centers to give their discounts to the uninsured, patients with high cost-sharing for insulin or Epi-Pens or a high unmet deductible.
It was originally slated to take effect Jan. 22, but HHS delayed it until Mar. 22. The Biden team could eventually withdraw the rule to prevent it from taking effect at all.

Community health centers, patient advocates and other groups pushed back on the rule when HHS proposed it last year, saying the changes were unnecessary and could do more harm than good. The National Association of Community Health Centers has said the rule reflects "a fundamental misunderstanding" of federally qualified health centers and the 340B program. And providers worried the regulation could reduce patients' access to care by cutting deeper into community health centers' thin operating margins.

The rule's pause follows a Wednesday memo from White House Chief of Staff Ron Klain directing agencies to freeze any new regulations ushered in during the end of Trump's term.
The pause will allow the incoming administration "to review any regulations that the Trump administration tried to finalize in its last days," according to a statement. "This action will allow the Biden administration to prevent any detrimental so-called 'midnight regulations' from taking effect while ensuring that urgent measures in the public's interest can proceed."
Republican lawmakers have expressed concern about expanding the 340B drug discount program. But their complaints have generally centered around hospitals, not community health clinics. Federally qualified health centers are legally required to reinvest any savings from 340B in community services, a standard that does not apply to hospitals.
Experts say the rule probably wouldn't make much of a dent in drug prices because it wouldn't affect most providers or patients. HHS admitted as much in its final rule, saying it would have "minimal economic impact."
Letter
Always making excuses for Biden I hope Biden and his supporters all rot in hell
 
For just fucking once I wish OP and Fox would get a story straight. Insurance companies who participated in the lower costs have not stopped a goddamn thing.



The Biden administration on Thursday delayed a rule that would block community health centers from receiving future grant funds unless they charge low-income patients the acquisition price for insulin and Epi-Pens, plus an administration fee.
HHS signed off on the rule in December, shortly before former President Donald Trump left office. It aims to lower patients' out-of-pocket costs by forcing community clinics to pass on their 340B drug discounts. The rule requires federally qualified health centers to give their discounts to the uninsured, patients with high cost-sharing for insulin or Epi-Pens or a high unmet deductible.
It was originally slated to take effect Jan. 22, but HHS delayed it until Mar. 22. The Biden team could eventually withdraw the rule to prevent it from taking effect at all.

Community health centers, patient advocates and other groups pushed back on the rule when HHS proposed it last year, saying the changes were unnecessary and could do more harm than good. The National Association of Community Health Centers has said the rule reflects "a fundamental misunderstanding" of federally qualified health centers and the 340B program. And providers worried the regulation could reduce patients' access to care by cutting deeper into community health centers' thin operating margins.

The rule's pause follows a Wednesday memo from White House Chief of Staff Ron Klain directing agencies to freeze any new regulations ushered in during the end of Trump's term.
The pause will allow the incoming administration "to review any regulations that the Trump administration tried to finalize in its last days," according to a statement. "This action will allow the Biden administration to prevent any detrimental so-called 'midnight regulations' from taking effect while ensuring that urgent measures in the public's interest can proceed."
Republican lawmakers have expressed concern about expanding the 340B drug discount program. But their complaints have generally centered around hospitals, not community health clinics. Federally qualified health centers are legally required to reinvest any savings from 340B in community services, a standard that does not apply to hospitals.
Experts say the rule probably wouldn't make much of a dent in drug prices because it wouldn't affect most providers or patients. HHS admitted as much in its final rule, saying it would have "minimal economic impact."
Letter

It would have made a difference to those it helped.

It has not been stopped at community health clinics, just paused for 60 days.

I'll let you know if insurance companies stop it.

I see Cory Booker all over. If it's good for the people and bad for Pharmaceutical companies, he will see that it gets stopped.
 
Chairman Joe helping his friends in big pharmacy but hurting the people he is supposed to help.....
Biden admin freezes Trump HHS rule meant to lower insulin prices
President Biden has been reversing or pausing some rules put in place under former President Donald Trump this week, including one designed to bring down the price of insulin.
The Department of Health and Human Services on Thursday announced that the directive would be put on hold among a number of other measures that were passed under Trump, but are not yet in effect.


It's part of a group is crap that's all being halted until it can be sorted through.
You keep making excuses. Prices will be goin up, up, up...Gas, energy, pharmacy...we going to hit them all. Bwhhaaa!
 
I just went and read up on this and what it proposed to do is pass the cost from the customers to the already underfunded clinic with no extra funding from the feds to cover it.

Doesn't sound like a great way to do this.
 
For just fucking once I wish OP and Fox would get a story straight. Insurance companies who participated in the lower costs have not stopped a goddamn thing.



The Biden administration on Thursday delayed a rule that would block community health centers from receiving future grant funds unless they charge low-income patients the acquisition price for insulin and Epi-Pens, plus an administration fee.
HHS signed off on the rule in December, shortly before former President Donald Trump left office. It aims to lower patients' out-of-pocket costs by forcing community clinics to pass on their 340B drug discounts. The rule requires federally qualified health centers to give their discounts to the uninsured, patients with high cost-sharing for insulin or Epi-Pens or a high unmet deductible.
It was originally slated to take effect Jan. 22, but HHS delayed it until Mar. 22. The Biden team could eventually withdraw the rule to prevent it from taking effect at all.

Community health centers, patient advocates and other groups pushed back on the rule when HHS proposed it last year, saying the changes were unnecessary and could do more harm than good. The National Association of Community Health Centers has said the rule reflects "a fundamental misunderstanding" of federally qualified health centers and the 340B program. And providers worried the regulation could reduce patients' access to care by cutting deeper into community health centers' thin operating margins.

The rule's pause follows a Wednesday memo from White House Chief of Staff Ron Klain directing agencies to freeze any new regulations ushered in during the end of Trump's term.
The pause will allow the incoming administration "to review any regulations that the Trump administration tried to finalize in its last days," according to a statement. "This action will allow the Biden administration to prevent any detrimental so-called 'midnight regulations' from taking effect while ensuring that urgent measures in the public's interest can proceed."
Republican lawmakers have expressed concern about expanding the 340B drug discount program. But their complaints have generally centered around hospitals, not community health clinics. Federally qualified health centers are legally required to reinvest any savings from 340B in community services, a standard that does not apply to hospitals.
Experts say the rule probably wouldn't make much of a dent in drug prices because it wouldn't affect most providers or patients. HHS admitted as much in its final rule, saying it would have "minimal economic impact."
Letter

It would have made a difference to those it helped.

It has not been stopped at community health clinics, just paused for 60 days.

I'll let you know if insurance companies stop it.
If you cannot get it now if has been stopped, quit fucking playing word games
 
I just went and read up on this and what it proposed to do is pass the cost from the customers to the already underfunded clinic with no extra funding from the feds to cover it.

Doesn't sound like a great way to do this.

Everyone in the administration has come out against UHC. They get no benefit of the doubt for anything here. It's obvious they are going to be slaves to the health industry just like in the past.
 
For just fucking once I wish OP and Fox would get a story straight. Insurance companies who participated in the lower costs have not stopped a goddamn thing.



The Biden administration on Thursday delayed a rule that would block community health centers from receiving future grant funds unless they charge low-income patients the acquisition price for insulin and Epi-Pens, plus an administration fee.
HHS signed off on the rule in December, shortly before former President Donald Trump left office. It aims to lower patients' out-of-pocket costs by forcing community clinics to pass on their 340B drug discounts. The rule requires federally qualified health centers to give their discounts to the uninsured, patients with high cost-sharing for insulin or Epi-Pens or a high unmet deductible.
It was originally slated to take effect Jan. 22, but HHS delayed it until Mar. 22. The Biden team could eventually withdraw the rule to prevent it from taking effect at all.

Community health centers, patient advocates and other groups pushed back on the rule when HHS proposed it last year, saying the changes were unnecessary and could do more harm than good. The National Association of Community Health Centers has said the rule reflects "a fundamental misunderstanding" of federally qualified health centers and the 340B program. And providers worried the regulation could reduce patients' access to care by cutting deeper into community health centers' thin operating margins.

The rule's pause follows a Wednesday memo from White House Chief of Staff Ron Klain directing agencies to freeze any new regulations ushered in during the end of Trump's term.
The pause will allow the incoming administration "to review any regulations that the Trump administration tried to finalize in its last days," according to a statement. "This action will allow the Biden administration to prevent any detrimental so-called 'midnight regulations' from taking effect while ensuring that urgent measures in the public's interest can proceed."
Republican lawmakers have expressed concern about expanding the 340B drug discount program. But their complaints have generally centered around hospitals, not community health clinics. Federally qualified health centers are legally required to reinvest any savings from 340B in community services, a standard that does not apply to hospitals.
Experts say the rule probably wouldn't make much of a dent in drug prices because it wouldn't affect most providers or patients. HHS admitted as much in its final rule, saying it would have "minimal economic impact."
Letter

It would have made a difference to those it helped.

It has not been stopped at community health clinics, just paused for 60 days.

I'll let you know if insurance companies stop it.
If you cannot get it now if has been stopped, quit fucking playing word games

It never actually started.
 
HHS signed off on the rule in December, shortly before former President Donald Trump left office. It aims to lower patients' out-of-pocket costs by forcing community clinics to pass on their 340B drug discounts. The rule requires federally qualified health centers to give their discounts to the uninsured, patients with high cost-sharing for insulin or Epi-Pens or a high unmet deductible.
Now why would Hitler want to reduce the cost of insulin for patients in need?
 

Forum List

Back
Top